Clinical Trial Update: An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG [Phase 3]

View source ↗

Summary

This update summarizes the completion of a Phase III open-label study evaluating the local tolerability of ZOMACTON 10MG in Turner syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Turner Syndrome

Drugs mentioned

• ZOMACTON 10MG (somatropin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Turner's Syndrome | Phase 3 | Status: COMPLETED